文献速递静脉血栓栓塞

导管接触性溶栓联合经皮机械性血栓清除术治疗急性髂股深静脉血栓的有效性与安全性:一项Meta分析

Effectiveness and safety of catheter-directed thrombolysis in conjunction with percutaneous mechanical thrombectomy for acute iliofemoral deep vein thrombosis: A meta-analysis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-03-07

这项Meta分析纳入20项研究共1686例急性髂股深静脉血栓患者,比较导管接触性溶栓联合经皮机械性血栓清除术与单纯导管接触性溶栓。联合组静脉通畅率和大腿消肿率更高,大出血并发症和术后2年内血栓后综合征发生率更低,溶栓时间和溶栓药物总量更少。

要点

  • 联合组静脉通畅率和大腿消肿率均高于单纯导管接触性溶栓组。
  • 联合组大出血并发症和术后2年内血栓后综合征发生率低于单纯溶栓组。
  • 联合组溶栓时间更短、溶栓药物总量更低,但纳入研究均为单中心队列研究。

核心结论

  • 导管接触性溶栓期间联合经皮机械性血栓清除术与更好的临床结局和更低的大出血并发症发生率相关。
  • 所纳入研究均为单中心队列研究,未来需要随机对照试验来证实这些发现。

研究设计与样本

  • 按照PRISMA指南进行的Meta分析,检索Medline、Embase、Cochrane Library、中国知网和万方数据。
  • 纳入随机对照试验和非随机研究,最终纳入20项符合条件的研究,共1686例患者。
  • 主要结局为静脉通畅率、大出血并发症和术后2年内血栓后综合征发生率;次要结局为溶栓时间、溶栓药物总量、大腿消肿率和髂静脉支架置入率。

主要发现

  • 联合经皮机械性血栓清除术组的静脉通畅率高于单纯导管接触性溶栓组(均数差10.11,95%CI 5.59-14.62)。
  • 联合组的大腿消肿率高于单纯溶栓组(均数差3.64,95%CI 1.10-6.18)。
  • 联合组大出血并发症少于单纯溶栓组(比值比0.45,95%CI 0.26-0.77)。
  • 联合组术后2年内血栓后综合征发生率低于单纯溶栓组(比值比0.55,95%CI 0.33-0.92)。
  • 联合组溶栓治疗时间更短,溶栓药物总量更低。

局限性

  • 所纳入研究均为单中心队列研究,未来需要随机对照试验来证实这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with severe acute low iliofemoral deep vein thrombosis (DVT), such as phlegmasia cerulea dolens, benefit from catheter-directed thrombolysis (CDT). This meta-analysis investigated the effectiveness and safety of adjuvant percutaneous mechanical thrombectomy (PMT) during CDT compared with CDT alone in the treatment of acute iliofemoral DVT. METHODS: A meta-analysis was performed in accordance with the PRISMA guidelines. Medline, Embase, the Cochrane Library, China National Knowledge Internet, and Wanfang data were searched for studies on the management of acute iliofemoral DVT by means of CDT or CDT with adjuvant PMT. Randomized, controlled trials and nonrandomized studies were included. The primary outcomes were venous patency rate, major bleeding complications, and post-thrombotic syndrome occurrence within 2 years of the procedure. The secondary outcomes were thrombolytic time and volume, as well as the rates of thigh detumescence and iliac vein stenting. RESULTS: The meta-analysis included 20 eligible studies with a total of 1686 patients. The rates of venous patency (mean difference, 10.11; 95% confidence interval [CI], 5.59-14.62) and thigh detumescence (mean difference, 3.64; 95% CI, 1.10-6.18) of the adjuvant PMT group were higher than those of the CDT alone group. Compared with CDT alone, the adjuvant PMT group experienced fewer incidences of major bleeding complications (odds ratio, 0.45; 95% CI, 0.26-0.77) and occurrences of post-thrombotic syndrome within 2 years of the procedure (odds ratio, 0.55; 95% CI, 0.33-0.92). Furthermore, the duration of thrombolytic therapy was shorter, and the total dose of administered thrombolytics was lower with adjuvant PMT. CONCLUSIONS: Adjuvant PMT during CDT is associated with improved clinical outcomes and a lower incidence of major bleeding complications. The studies investigated were, however, single-center cohort studies, and future randomized controlled trials are needed to substantiate these findings.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Li W, Zaid Al-Kaylani A, Zeebregts CJ, et al. Effectiveness and safety of catheter-directed thrombolysis in conjunction with percutaneous mechanical thrombectomy for acute iliofemoral deep vein thrombosis: A meta-analysis. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36893883. doi:10.1016/j.jvsv.2023.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。